Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT05120869
Official study title

Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention

Study summary

Healthcare providers (HCP) serving the El Paso U.S.-Mexico Border Region will be recruited to compare educational and professional skills interventions focused on the human papillomavirus (HPV). Our hypothesis is that improving provider knowledge and communication strategies about HPV and its vaccine will reduce hesitancy and increase uptake and completion among the populations they serve.

Ask AI to explain this study
Start here

Key things to know

Main goalOther

This describes the study’s primary purpose.

What is being studiedTailored HPV Education and Professional Skills Intervention Group and General HPV Education and Communication Skills Control Group

The study team can explain what participation involves.

Who it may be forHealth Personnel Attitude · Health Knowledge, Attitudes, Practice

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 25, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?University of Texas, El Paso

Study sponsor

01
Study overview

What this study is about

Purpose
Other
Study type
Interventional
Phase
Not applicable
Sponsor
University of Texas, El Paso
Interventions being studied
Behavioral: Tailored HPV Education and Professional Skills Intervention Group; Behavioral: General HPV Education and Communication Skills Control Group
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Current (in practice) or emerging (in training - medical student, resident, or fellow) healthcare provider
  • Working/training or living in the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico)
  • Have the authorization to recommend/prescribe/administer the HPV vaccine
Reasons someone may not be able to joinExclusion criteria
  • Unaffiliated with the El Paso U.S.-Mexico Border Region (i.e., El Paso County, TX-Southern New Mexico)
  • Participation in Phases I or II of the larger research project \[cross-sectional phases\]
  • Does not identify as a current or emerging healthcare provider
  • Declines or is unable to participate in the full intervention and follow-up time-points
  • Unable to complete participation and activities in the English language

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Burrell College of Osteopathic MedicineLas Cruces, New Mexico
  • The University of Texas at El Paso, Border Biomedical Research CenterEl Paso, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 25, 2026. Always confirm current availability with the study team.

View original record ↗